Norbormide enhances late steps of steroid-hormone synthesis in rat and mouse adrenal cortex.
Norbormide (N) is a vasoconstrictor agent, which acts selectively on the peripheral arteries of the rat, through the activation of the phospholipase C (PLC) cascade and the stimulation of Ca(2+) entrance in the vascular myocytes. Several endogenous vasoconstrictor agent (e.g. angiotensin-II (ANG-II) and endothelin-1 (ET-1)), that stimulate PLC pathway, are also able to enhance aldosterone secretion by the adrenal gland. Hence, we examined the effects of norbormide ((0.5, 1.0 or 5) x 10(-5)M) on corticosteroid-hormone secretion from adrenal slices of rats and mice. Quantitative HPLC assay showed that under basal conditions rat and mouse adrenal quarters secreted progesterone (PROG), 11-deoxycorticosterone (DOC), 18-hydroxy-DOC (18OH-DOC), corticosterone (CORT), 18-hydroxy-corticosterone (18OH-CORT) and aldosterone (ALDO), as well as large amounts of pregnenolone (PREG) when its metabolism was blocked by 10(-5)M cyanoketone. Norbormide concentration-dependently raised the secretion of all post-DOC steroids assayed, decreased progesterone and DOC production, and did not affect pregnenolone release. In conclusion, norbormide is able to enhance late steps of steroid synthesis, i.e. those leading to the transformation of DOC to corticosterone and aldosterone, without affecting early steps. This is an interesting finding because the other main endogenous adrenal secretagogues are known to stimulate both early and late steps of steroid synthesis. The mechanism underlying the selective activating action of norbormide on 11beta- and 18-hydroxylation remains to be investigated.
Department of Human Anatomy and Physiology, Section of Anatomy, University of Padua, Via Gabelli 65, I-35121 Padua, Italy.
Giuliano
G
Neri
Cinzia
C
Tortorella
Paola G
PG
Andreis
Sergio
S
Bova
Ludwik K
LK
Malendowicz
Agnieszka
A
Ziolkowska
Gastone G
GG
Nussdorfer
D015069:18-Hydroxycorticosterone / Q000494:pharmacology; D000302:Adrenal Cortex / Q000187:drug effects* / Q000378:metabolism; D000311:Adrenal Glands / Q000378:metabolism; D000450:Aldosterone / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism; D003345:Corticosterone / Q000494:pharmacology; D003489:Cyanoketone / Q000494:pharmacology; D005938:Glucocorticoids / Q000494:pharmacology; D051379:Mice; D008956:Models, Chemical; D009132:Muscles / Q000166:cytology; D009636:Norbornanes / Q000494:pharmacology*; D051381:Rats; D013256:Steroids / Q000096:biosynthesis*; D013997:Time Factors; D010738:Type C Phospholipases / Q000378:metabolism
D005938:Glucocorticoids; D009636:Norbornanes; D013256:Steroids; D003489:Cyanoketone; D000450:Aldosterone; D015069:18-Hydroxycorticosterone; D010738:Type C Phospholipases; C005321:norbormide; D002118:Calcium; D003345:Corticosterone